Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. Mental Health Challenges. Disclaimer.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

OCTOBER 5, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it will present at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on Thursday, October 7, 2021. The Company’s presentation will be available for viewing that day at 10:10 a.m.

Pharmaceutical 40

Pharmaceutical Clinical Trials Chronic Pain Media 40

Cannabis Law Report

MARCH 29, 2020

o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Cannigma

JULY 1, 2022

What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible. The cannabis research problem.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. Media Contact: media@mindmed.co. Except as required by law, the Company does not intend and does not assume any obligation to update this forward-looking information. Investor Contact: ir@mindmed.co.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

NOVEMBER 24, 2019

Johnson will be speaking at Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks conference in Washington DC. Dr. Griffiths will be providing background on psilocybin, and Dr. Johnson will be presenting on recommendations for leveraging psilocybin treatment of opioid addiction.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Cannabis Law Report

JANUARY 13, 2020

Justin Gover, GW’s Chief Executive Officer expects to discuss these updates as part of a webcast presentation at the 38 th Annual J.P. Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020. Mike Beyer.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. “We

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Media coverage of the paper led to a new stigma and political pressure ended the Spain MDMA study. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. Minister for Industry and Skills David Pisoni published a media release to mark the occasion, entitled South Australia welcomes cannabis industry leaders.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Otherside Farms

NOVEMBER 3, 2019

The “entourage effect” is the latest buzz in cannabis media, presenting a well-formed scientific hypothesis that cannabinoids don’t just work on their own. The research on the topic of the entourage effect is scarce, at least in terms of pre-clinical trials. What we don’t know. Is it really that simple?

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

The Cannigma

JUNE 24, 2021

Meditation can also help people focus themselves on the here and now, away from anxieties about the present and regrets of the past. The constant distractions, notifications, and social media outrages of the day can also boost your anxiety and stress, and make it much harder to just live in the moment.

CBD 99

CBD Microdosing Edibles Sleep 99

Cannabis Law Report

JULY 23, 2019

Freia (www.freiafarmaceutici.it) was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed for sale throughout the EU. Media – Kellie Coppin: kcoppin@renmarkfinancial.com.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

JANUARY 11, 2019

However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited. 9] While that portion of the statement provoked a few breathless media reports, it was old news.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

MMJ Recs

DECEMBER 22, 2023

Media Portrayal and Its Role in Shaping Medical Cannabis Attitudes Media plays a pivotal role in shaping public perception, and the portrayal of medical cannabis is no exception. The changing face of cannabis in popular media, literature, and entertainment has contributed to a more nuanced understanding of its potential benefits.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. The agency maintains that they need more time to probe further into the science of cannabidiol, which will require thorough research and clinical trials before they can conclude certain products as GRAS. “To

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

FEBRUARY 28, 2020

The feeling of “we’re all going to get rich” soon began to permeate through almost every Bitcoin conference and event as mainstream media attention grew, and once the sheen came off and businesses began to pivot to blockchain, there was an air of desperation. We’re not all going to get rich. Perhaps we can rectify this in the Second Edition?

Law 59

Law Research and Development Recreational Cannabis 59

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. This article analyses media representations of medicinal cannabis in Australian medical publications. Media framing of cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Investor Presentation Information. Eleusis and Silver Spike have prepared a prerecorded investor presentation.

Therapy 40

Therapy Research and Development Business Access 40

FloridaMarijuana.net

JUNE 13, 2018

Mainstream media has begun to illustrate just how effective medical marijuana can be in helping cancer patients. Oral : Oral administration of medical cannabis may present an effective option for patients when other treatments and managements are not successful.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

JULY 24, 2019

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. Anxiety, depression, post-traumatic stress disorders, and even schizophrenia.

CBD 51

CBD Tincture Pets Chronic Pain 51

Weedistry

JANUARY 28, 2019

It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring. Something needs to be done”: Making medicine attainable and affordable.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. The Essay presents proposals to reduce the risk of biopiracy and the issuance of unwarranted psychedelic patents. Trial of Psilocybin Versus Escitalopram for Depression , 384 NEW ENG. Mitchell et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. With these excessive mold counts, you’d very likely have mycotoxins present.

DEA 235

DEA Research and Development Clinical Trials Patients 235